Life
Pharma companies and patient groups seek to exempt orphan drugs from Colorado pricing limits
Strategic angle: A bill is moving through the Colorado legislature that would exempt orphan drugs from pricing caps that might be pursued by the state.
editorial-staff
1 min read
Updated 5 days ago
The Colorado legislature is currently considering a bill that would specifically exempt orphan drugs from any pricing limits that the state may implement.
This move comes amid broader discussions on pharmaceutical pricing and access, particularly for drugs that treat rare diseases.
The implications of this legislation could significantly affect the market dynamics for orphan drugs, influencing both pricing strategies and patient access.